Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 9595706, 12 pages
http://dx.doi.org/10.1155/2016/9595706
Research Article

Systemic and Local Administration of Antimicrobial and Cell Therapies to Prevent Methicillin-Resistant Staphylococcus epidermidis-Induced Femoral Nonunions in a Rat Model

1Cell and Tissue Engineering Laboratory, IRCCS Galeazzi Orthopaedic Institute, 20161 Milan, Italy
2Laboratory of Clinical Chemistry and Microbiology, IRCCS Galeazzi Orthopaedic Institute, 20161 Milan, Italy
3Department of Biomedical Science for Health, University of Milan, 20133 Milan, Italy
4Department of Veterinary Medicine (DiMeVet), University of Milan, 20133 Milan, Italy
5MAP Laboratory, Fondazione Filarete, 20139 Milan, Italy
6Laboratory of Experimental Biochemistry & Molecular Biology, IRCCS Galeazzi Orthopaedic Institute, 20161 Milan, Italy
7Department of Reconstructive Surgery of Osteoarticular Infections, CRIO Unit, IRCCS Galeazzi Orthopaedic Institute, 20161 Milan, Italy

Received 1 March 2016; Revised 6 June 2016; Accepted 8 June 2016

Academic Editor: Vera L. Petricevich

Copyright © 2016 Arianna B. Lovati et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. E. Moore, K. Baldwin, M. S. Austin, and S. Mehta, “A systematic review of open reduction and internal fixation of periprosthetic femur fractures with or without allograft strut, cerclage, and locked plates,” Journal of Arthroplasty, vol. 29, no. 5, pp. 872–876, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Ribeiro, F. J. Monteiro, and M. P. Ferraz, “Infection of orthopedic implants with emphasis on bacterial adhesion process and techniques used in studying bacterial-material interactions,” Biomatter, vol. 2, no. 4, pp. 176–194, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. A. E. Namvar, S. Bastarahang, N. Abbasi et al., “Clinical characteristics of Staphylococcus epidermidis: a systematic review,” GMS Hygiene and Infection Control, vol. 9, no. 3, pp. 1–10, 2014. View at Publisher · View at Google Scholar
  4. K. C. Reiter, B. Villa, T. G. D. S. Paim, C. F. de Oliveira, and P. A. d'Azevedo, “Inhibition of biofilm maturation by linezolid in meticillin-resistant Staphylococcus epidermidis clinical isolates: comparison with other drugs,” Journal of Medical Microbiology, vol. 62, no. 3, pp. 394–399, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Sahal and I. S. Bilkay, “Multi drug resistance in strong biofilm forming clinical isolates of Staphylococcus epidermidis,” Brazilian Journal of Microbiology, vol. 45, no. 2, pp. 539–544, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. G.-J. A. ter Boo, D. W. Grijpma, T. F. Moriarty, R. G. Richards, and D. Eglin, “Antimicrobial delivery systems for local infection prophylaxis in orthopedic- and trauma surgery,” Biomaterials, vol. 52, no. 1, pp. 113–125, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Drago, W. Boot, K. Dimas et al., “Does implant coating with antibacterial-loaded hydrogel reduce bacterial colonization and biofilm formation in vitro?” Clinical Orthopaedics and Related Research, vol. 472, no. 11, pp. 3311–3323, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Giavaresi, E. Meani, M. Sartori et al., “Efficacy of antibacterial-loaded coating in an in vivo model of acutely highly contaminated implant,” International Orthopaedics, vol. 38, no. 7, pp. 1505–1512, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. C. L. Roman, G. Giammona, R. Giardino, and E. Meani, “Antibiotic-loaded resorbable hydrogel coating for infection prophylaxis of orthopaedic implants. Preliminary studies,” The Journal of Bone & Joint Surgery—British Volume, vol. 93, pp. 337–338, 2011. View at Google Scholar
  10. E. Gómez-Barrena, P. Rosset, D. Lozano, J. Stanovici, C. Ermthaller, and F. Gerbhard, “Bone fracture healing: cell therapy in delayed unions and nonunions,” Bone, vol. 70, pp. 93–101, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. R. R. Sharma, K. Pollock, A. Hubel, and D. McKenna, “Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices,” Transfusion, vol. 54, no. 5, pp. 1418–1437, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Wu, Y. Liu, B. Wang, and G. Li, “The roles of mesenchymal stem cells in tissue repair and disease modification,” Current Stem Cell Research and Therapy, vol. 9, no. 5, pp. 424–431, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Seebach, J. Holschbach, N. Buchta, R. G. Bitsch, K. Kleinschmidt, and W. Richter, “Mesenchymal stromal cell implantation for stimulation of long bone healing aggravates Staphylococcus aureus induced osteomyelitis,” Acta Biomaterialia, vol. 21, pp. 165–177, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Yuan, S. lin, N. Guo et al., “Marrow mesenchymal stromal cells reduce methicillin-resistant Staphylococcus aureus infection in rat models,” Cytotherapy, vol. 16, no. 1, pp. 56–63, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. A. B. Lovati, C. L. Romanò, M. Bottagisio et al., “Modeling staphylococcus epidermidis-induced non-unions: subclinical and clinical evidence in rats,” PLoS ONE, vol. 11, no. 1, Article ID e0147447, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Lelubre, S. Anselin, K. Z. Boudjeltia, P. Biston, and M. Piagnerelli, “Interpretation of C-reactive protein concentrations in critically ill patients,” BioMed Research International, vol. 2013, Article ID 124021, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Shah, A. Mohammed, S. Patil, A. McFadyen, and R. M. D. Meek, “Circulating cytokines after hip and knee arthroplasty: A Preliminary Study,” Clinical Orthopaedics and Related Research, vol. 467, no. 4, pp. 946–951, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. O. Bastian, J. Pillay, J. Alblas, L. Leenen, L. Koenderman, and T. Blokhuis, “Systemic inflammation and fracture healing,” Journal of Leukocyte Biology, vol. 89, no. 5, pp. 669–673, 2011. View at Publisher · View at Google Scholar
  19. K. R. O'Neill, C. M. Stutz, N. A. Mignemi et al., “Micro-computed tomography assessment of the progression of fracture healing in mice,” Bone, vol. 50, no. 6, pp. 1357–1367, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Drago, C. L. Romanò, R. Mattina, V. Signori, and E. De Vecchi, “Does dithiothreitol improve bacterial detection from infected prostheses? A pilot study infection,” Clinical Orthopaedics and Related Research, vol. 470, no. 10, pp. 2915–2925, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. U. Klier, C. Maletzki, N. Göttmann, B. Kreikemeyer, and M. Linnebacher, “Avitalized bacteria mediate tumor growth control via activation of innate immunity,” Cellular Immunology, vol. 269, no. 2, pp. 120–127, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Freyman, G. Polin, H. Osman et al., “A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction,” European Heart Journal, vol. 27, no. 9, pp. 1114–1122, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. T. J. Kean, P. Lin, A. I. Caplan, and J. E. Dennis, “MSCs: delivery routes and engraftment, cell-targeting strategies, and immune modulation,” Stem Cells International, vol. 2013, Article ID 732742, 13 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. I. M. Barbash, P. Chouraqui, J. Baron et al., “Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution,” Circulation, vol. 108, no. 7, pp. 863–868, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Kyriakou, N. Rabin, A. Pizzey, A. Nathwani, and K. Yong, “Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model,” Haematologica, vol. 93, no. 10, pp. 1457–1465, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Furlani, M. Ugurlucan, L. Ong et al., “Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy,” Microvascular Research, vol. 77, no. 3, pp. 370–376, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. J. W. Jung, M. Kwon, J. C. Choi et al., “Familial occurrence of pulmonary embolism after intravenous, adipose tissue-derived stem cell therapy,” Yonsei Medical Journal, vol. 54, no. 5, pp. 1293–1296, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Moll and K. Le Blanc, “Engineering more efficient multipotent mesenchymal stromal (stem) cells for systemic delivery as cellular therapy,” ISBT Science Series, vol. 10, pp. 357–365, 2015. View at Publisher · View at Google Scholar
  29. G. Lombardi, F. Sanchis-Gomar, S. Perego, V. Sansoni, and G. Banfi, “Implications of exercise-induced adipo-myokines in bone metabolism,” Endocrine, pp. 1–22, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Müller-Alouf, C. Carnoy, M. Simonet, and J. E. Alouf, “Superantigen bacterial toxins: state of the art,” Toxicon, vol. 39, no. 11, pp. 1691–1701, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Chung, J. C. Cool, M. A. Scherer, B. K. Foster, and C. J. Xian, “Roles of neutrophil-mediated inflammatory response in the bony repair of injured growth plate cartilage in young rats,” Journal of Leukocyte Biology, vol. 80, no. 6, pp. 1272–1280, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. J. G. Andrew, S. M. Andrew, A. J. Freemont, and D. R. Marsh, “Inflammatory cells in normal human fracture healing,” Acta Orthopaedica, vol. 65, no. 4, pp. 462–466, 1994. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Bode, S. Muenster, B. Diedrich et al., “Linezolid, vancomycin and daptomycin modulate cytokine production, Toll-like receptors and phagocytosis in a human in vitro model of sepsis,” Journal of Antibiotics, vol. 68, no. 8, pp. 485–490, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. S. B. Goodman, Z. Yao, M. Keeney, and F. Yang, “The future of biologic coatings for orthopaedic implants,” Biomaterials, vol. 34, no. 13, pp. 3174–3183, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Pierrakos and J.-L. Vincent, “Sepsis biomarkers: a review,” Critical Care, vol. 14, no. 1, article R15, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Yoshitake, S. Itoh, H. Narita, K. Ishihara, and S. Ebisu, “Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-κB signaling pathways,” The Journal of Biological Chemistry, vol. 283, no. 17, pp. 11535–11540, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Lombardi, F. Sanchis-Gomar, S. Perego, V. Sansoni, and G. Banfi, “Implications of exercise-induced adipo-myokines in bone metabolism,” Endocrine, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. X. Wei, X. Yang, Z.-P. Han, F.-F. Qu, L. Shao, and Y.-F. Shi, “Mesenchymal stem cells: a new trend for cell therapy,” Acta Pharmacologica Sinica, vol. 34, no. 6, pp. 747–754, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Tyndall and V. Pistoia, “Mesenchymal stem cells combat sepsis,” Nature Medicine, vol. 15, no. 1, pp. 18–20, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Ma, N. Xie, W. Li, B. Yuan, Y. Shi, and Y. Wang, “Immunobiology of mesenchymal stem cells,” Cell Death and Differentiation, vol. 21, no. 2, pp. 216–225, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. R. De Waal Malefyt, J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries, “Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes,” The Journal of Experimental Medicine, vol. 174, no. 5, pp. 1209–1220, 1991. View at Publisher · View at Google Scholar · View at Scopus